We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-6.16%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$73.7M
AUM Growth
–
Cap. Flow
+$52M
Cap. Flow %
70.6%
Top 10 Hldgs %
77.46%
Holding
47
New
43
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EMWP
Eros Media World PLC
EMWP
+$9.73M
2
ADC icon
Agree Realty
ADC
+$5.36M
3
AKBA icon
Akebia Therapeutics
AKBA
+$4.58M
4
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$3.73M
5
ZSAN
Zosano Pharma Corporation
ZSAN
+$3.58M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Communication Services 12.09%
3 Real Estate 8.5%
4 Materials 2.36%
5 Energy 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXIIW
26
DELISTED
RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
$100K 0.14%
+221,686
New +$144K
CLRBZ
27
DELISTED
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
$87K 0.12%
+207,500
New +$102K
BVXVW
28
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$87K 0.12%
+72,800
New +$113K
IMRNW
29
DELISTED
Immuron Limited Warrants
IMRNW
$86K 0.12%
+22,041
New +$53.4K
SGLBW
30
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$81K 0.11%
+215,300
New +$89.4K
AMRHW
31
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$56K 0.08%
+125,503
New +$87.9K
ONTXW
32
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$52K 0.07%
+173,112
New +$64.9K
SNGXW
33
DELISTED
Soligenix, Inc. Warrant
SNGXW
$35K 0.05%
+61,000
New +$35.8K
APOPW
34
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$24K 0.03%
+12,570
New +$28.5K
BNTCW
35
DELISTED
Benitec Biopharma Limited
BNTCW
$12K 0.02%
+50,000
New +$17.7K
APDNW
36
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$8K 0.01%
+31,407
New +$10.3K
ADXSW
37
DELISTED
Advaxis Inc Warrants
ADXSW
$6K 0.01%
+15,150
New +$9.49K
MYNDW
38
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$4K 0.01%
+13,700
New +$5.35K
NSPRZ
39
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$1K ﹤0.01%
+48,000
New +$1.33K
EYEGW
40
DELISTED
Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
$1K ﹤0.01%
+12,900
New +$1.57K
UUUU.WS
41
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
+277,777
New +$184K
CVM.WS
42
DELISTED
Cel-Sci Corp Series S
CVM.WS
$0 ﹤0.01%
+750,000
New +$19.6K
1
2

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q1 2018 Portfolio in Review

Q1 2018 is the first quarter with a 13F filing on record for CVI Holdings, which disclosed 47 positions worth $73.7M. Its ten largest holdings account for 77% of the portfolio.

Its largest position is Eros Media World PLC: 40,851 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Communication Services and Real Estate.

  • CVI Holdings's largest Q1 2018 buy was Eros Media World PLC: 40,851 shares worth $8.9M.
  • CVI Holdings's ten largest holdings make up 77% of its $73.7M portfolio in Q1 2018.
  • CVI Holdings disclosed 47 positions in Q1 2018, its first 13F filing on record.

Based on CVI Holdings's 13F filing for Q1 2018, filed 15 May 2018.